Hao Jing-bo

MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc.

L. Tao, Liu Xiang-qun, H. Rong, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.